LifeTech Scientific Corporation (HKG: 1302)

LifeTech Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	832.58	979.31	833.79	1,119	971.68	299.03
Short-Term Investments	60.91	80	-	158.11	170.99	50
Trading Asset Securities	148	120	-	199	-	-
Cash & Short-Term Investments	1,041	1,179	833.79	1,476	1,143	349.03
Cash Growth	5.72%	41.44%	-43.52%	29.20%	227.39%	-2.39%
Accounts Receivable	122.17	105.19	137.09	110.04	107.14	72.55
Other Receivables	89.75	78.62	78.45	51.92	37.59	27.47
Receivables	211.92	183.81	215.54	161.96	144.73	100.02
Inventory	549.56	483.61	241.41	129.29	99.62	99.13
Other Current Assets	415.65	384.42	105.92	69.45	157.82	57.63
Total Current Assets	2,219	2,231	1,397	1,837	1,545	605.8
Property, Plant & Equipment	983.61	884.86	783.39	724.07	483.52	448.18
Long-Term Investments	481.25	531.71	725.5	48.63	421.03	183.33
Other Intangible Assets	714.9	75.15	84.42	76.07	35.48	42.77
Long-Term Deferred Tax Assets	102.47	83.03	62.6	47	35.9	32.3
Long-Term Deferred Charges	-	581.52	357.99	288.76	269.42	216.14
Other Long-Term Assets	318.73	308.95	279.56	162.12	164.36	243.71
Total Assets	4,820	4,696	3,690	3,184	2,955	1,772
Accounts Payable	452.64	124.09	62.65	30.76	18.71	9.92
Accrued Expenses	221.3	284.58	290.88	237.14	143.51	117.53
Current Portion of Long-Term Debt	99	-	-	-	174.46	113.42
Current Portion of Leases	3.53	6.29	5.04	11.05	6.85	11.66
Current Income Taxes Payable	46.56	45.94	37.82	34.03	33.03	37.57
Current Unearned Revenue	3.5	12.5	13.17	11.43	19.35	9.17
Other Current Liabilities	-	296.74	175.18	157.51	97.68	41.95
Total Current Liabilities	826.52	770.14	584.74	481.91	493.6	341.22
Long-Term Debt	-	-	-	-	-	216.85
Long-Term Leases	1.88	3	4.64	4.63	4.67	11.53
Long-Term Unearned Revenue	42.56	40.93	37.17	32.08	30.29	40.97
Other Long-Term Liabilities	558.33	558.33	142.5	135	67.5	-
Total Liabilities	1,429	1,372	769.05	653.61	596.06	610.56
Common Stock	0.04	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	-	1,643	1,628	1,621	1,608	778.64
Retained Earnings	-	1,702	1,439	1,114	821.4	605.37
Comprehensive Income & Other	3,422	24.94	-166.88	-231.38	-89.24	-232.03
Total Common Equity	3,422	3,370	2,900	2,504	2,340	1,152
Minority Interest	-32.18	-46.27	20.61	26.52	18.35	9.65
Shareholders' Equity	3,390	3,324	2,921	2,530	2,358	1,162
Total Liabilities & Equity	4,820	4,696	3,690	3,184	2,955	1,772
Total Debt	104.42	9.3	9.67	15.67	185.98	353.45
Net Cash (Debt)	937.07	1,170	824.12	1,461	956.69	-4.42
Net Cash Growth	-3.47%	41.97%	-43.58%	52.68%	-	-
Net Cash Per Share	0.21	0.26	0.19	0.32	0.22	-0.00
Filing Date Shares Outstanding	4,631	4,630	4,630	4,630	4,627	4,320
Total Common Shares Outstanding	4,631	4,630	4,630	4,630	4,627	4,320
Working Capital	1,392	1,461	811.92	1,355	1,051	264.58
Book Value Per Share	0.74	0.73	0.63	0.54	0.51	0.27
Tangible Book Value	2,708	3,295	2,816	2,428	2,305	1,109
Tangible Book Value Per Share	0.58	0.71	0.61	0.52	0.50	0.26
Buildings	-	641.54	560.72	198.81	198.07	192.83
Machinery	-	306.4	262.72	265.59	254.53	243.92
Construction In Progress	-	76.04	55.31	325.06	65.83	9.69
Leasehold Improvements	-	30.57	28.61	20.44	23.17	17.88

Source: S&P Capital IQ. Standard template. Financial Sources.